Capmatinib response in patients with advanced non–small cell lung cancer (NSCLC) harboring focal MET amplifications: Analysis from the phase 2, multicohort GEOMETRY mono-1 study

J. Wolf; E. B. Garon; H. J.M. Groen; D. S.W. Tan; S. Le Mouhaer; M. Riester; L. Ji; A. Robeva; L. Fairchild; A. Boran; R. S. Heist

doi:10.1016/S0959-8049(22)00859-0

Capmatinib response in patients with advanced non–small cell lung cancer (NSCLC) harboring focal MET amplifications: Analysis from the phase 2, multicohort GEOMETRY mono-1 study

J. Wolf
, E. B. Garon
, H. J.M. Groen
, D. S.W. Tan
, S. Le Mouhaer
, M. Riester
, L. Ji
, A. Robeva
, L. Fairchild
, A. Boran
, R. S. Heist

Research output: Contribution to journal › Meeting Abstract › Academic

1 Citation (Scopus)

Original language	English
Pages (from-to)	S21
Number of pages	1
Journal	European Journal of Cancer
Volume	174
DOIs	https://doi.org/10.1016/S0959-8049(22)00859-0
Publication status	Published - Oct-2022

Access to Document

10.1016/S0959-8049(22)00859-0

Handle.net

Persistent link

Cite this

Wolf, J., Garon, E. B., Groen, H. J. M., Tan, D. S. W., Le Mouhaer, S., Riester, M., Ji, L., Robeva, A., Fairchild, L., Boran, A., & Heist, R. S. (2022). Capmatinib response in patients with advanced non–small cell lung cancer (NSCLC) harboring focal MET amplifications: Analysis from the phase 2, multicohort GEOMETRY mono-1 study. European Journal of Cancer, 174, S21. https://doi.org/10.1016/S0959-8049(22)00859-0

@article{8282646c81d74cddbd7d2cfa720270ae,

title = "Capmatinib response in patients with advanced non–small cell lung cancer (NSCLC) harboring focal MET amplifications: Analysis from the phase 2, multicohort GEOMETRY mono-1 study",

author = "J. Wolf and Garon, \{E. B.\} and Groen, \{H. J.M.\} and Tan, \{D. S.W.\} and \{Le Mouhaer\}, S. and M. Riester and L. Ji and A. Robeva and L. Fairchild and A. Boran and Heist, \{R. S.\}",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)00859-0",

language = "English",

volume = "174",

pages = "S21",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "ELSEVIER SCI LTD",

}

Wolf, J, Garon, EB, Groen, HJM, Tan, DSW, Le Mouhaer, S, Riester, M, Ji, L, Robeva, A, Fairchild, L, Boran, A & Heist, RS 2022, 'Capmatinib response in patients with advanced non–small cell lung cancer (NSCLC) harboring focal MET amplifications: Analysis from the phase 2, multicohort GEOMETRY mono-1 study', European Journal of Cancer, vol. 174, pp. S21. https://doi.org/10.1016/S0959-8049(22)00859-0

TY - JOUR

T1 - Capmatinib response in patients with advanced non–small cell lung cancer (NSCLC) harboring focal MET amplifications

T2 - Analysis from the phase 2, multicohort GEOMETRY mono-1 study

AU - Wolf, J.

AU - Garon, E. B.

AU - Groen, H. J.M.

AU - Tan, D. S.W.

AU - Le Mouhaer, S.

AU - Riester, M.

AU - Ji, L.

AU - Robeva, A.

AU - Fairchild, L.

AU - Boran, A.

AU - Heist, R. S.

PY - 2022/10

Y1 - 2022/10

U2 - 10.1016/S0959-8049(22)00859-0

DO - 10.1016/S0959-8049(22)00859-0

M3 - Meeting Abstract

AN - SCOPUS:85140487899

SN - 0959-8049

VL - 174

SP - S21

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -